Who owns SAREPTA THERAPEUTICS INC NOTE 1.250 9/1?
- CUSIP Number: 803607ad2
Tip: Access positions for across all investors
Analyze quarterly positions in Sarepta Therapeutics Inc Note 1.250 9/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sarepta Therapeutics Inc Note 1.250 9/1 stock
Who bought or sold SAREPTA THERAPEUTICS INC NOTE 1.250 9/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wolverine Asset Management | 74M | $86M | -3% | Mar 2024 |
|
| Calamos Advisors | 59M | $70M | 0% | Mar 2024 |
|
| BlackRock | 53M | $62M | 577% | Mar 2024 |
|
| Braidwell | 51M | $59M | 0% | Mar 2024 |
|
| Lazard Asset Management | 40M | $41M | -17% | Dec 2023 |
|
| Davidson Kempner Capital Management | 40M | $47M | -11% | Mar 2024 |
|
| Readystate Asset Management | 37M | $43M | -14% | Mar 2024 |
|
| Citadel Advisors | 33M | $39M | 100% | Mar 2024 |
|
| Steelhead Partners | 32M | $38B | 109% | Mar 2024 |
|
| Bank of America Corporation | 32M | $37M | -24% | Mar 2024 |
|
| D. E. Shaw & Co | 31M | $36M | -15% | Mar 2024 |
|
| Tenor Capital Management | 25M | $29B | -35% | Mar 2024 |
|
| Bank Of Montreal | 25M | $29M | -8% | Mar 2024 |
|
| FMR | 25M | $29M | 67% | Mar 2024 |
|
| Nuveen Asset Management | 20M | $23M | 100% | Mar 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 16M | $19M | 0% | Mar 2024 |
|
| Lombard Odier Asset Management | 12M | $14M | 4% | Mar 2024 |
|
| Ameriprise Financial | 8.4M | $9.8M | -15% | Mar 2024 |
|
| Morgan Stanley | 8.2M | $9.5M | -20% | Mar 2024 |
|
| Capstone Investment Advisors | 7.0M | $8.2M | -22% | Mar 2024 |
|
| Axa | 6.1M | $7.1M | -5% | Mar 2024 |
|
| Mint Tower Capital Management B.V. | 6.0M | $7.0M | -43% | Mar 2024 |
|
| Jpmorgan Chase & Co | 5.5M | $6.4M | 117% | Mar 2024 |
|
| SSI Investment Management | 5.4M | $5.5M | -1% | Dec 2023 |
|
| New York State Common Retirement Fund | 5.3M | $6.1M | -37% | Mar 2024 |
|
| Man Group | 5.1M | $5.9M | -4% | Mar 2024 |
|
| Bnp Paribas Investment Partners | 4.9M | $5.6M | 100% | Mar 2024 |
|
| RWC Asset Management | 4.7M | $5.5M | 9% | Mar 2024 |
|
| Franklin Resources | 4.0M | $4.7M | 100% | Mar 2024 |
|
| Ofi Invest Asset Management | 4.0M | $9.0M | 121233% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 3.8M | $4.5M | 112% | Mar 2024 |
|
| Royal Bank of Canada | 3.6M | $4.1M | 100% | Mar 2024 |
|
| Amundi | 3.5M | $3.8M | 0% | Mar 2024 |
|
| Wells Fargo & Company | 3.3M | $3.9M | 279% | Mar 2024 |
|
| Wellesley Investment Advisors | 2.8M | $2.8B | 100% | Dec 2023 |
|
| Shenkman Capital Management | 2.7M | $3.2B | -23% | Mar 2024 |
|
| Edmond De Rothschild Holding | 1.9M | $2.2M | 0% | Mar 2024 |
|
| Palisade Capital Management | 1.8M | $2.1M | -13% | Mar 2024 |
|
| Agf Management | 1.7M | $2.0M | 0% | Mar 2024 |
|
| Lord, Abbett & Co | 1.3M | $1.5M | 100% | Mar 2024 |
|
| Bank of New York Mellon | 900k | $1.1M | 0% | Mar 2024 |
|
| Groupama Asset Managment | 800k | $867k | 0% | Mar 2024 |
|
| Zurcher Kantonalbank | 650k | $756k | -13% | Mar 2024 |
|
| Russell Investments | 382k | $447k | -15% | Mar 2024 |
|
| Citigroup | 322k | $375k | 173% | Mar 2024 |
|
| KBC Group NV | 300k | $351k | 0% | Mar 2024 |
|
| SG Americas Securities | 291k | $34M | 645% | Mar 2024 |
|
| Central Pacific Bank - Trust Division | 276k | $321k | 100% | Mar 2024 |
|
| First Hawaiian Bank | 109k | $127k | 0% | Mar 2024 |
|
| Calamos Wealth Management | 78k | $91k | 42% | Mar 2024 |
|
| Aurum Wealth Management Group | 17k | $17k | 100% | Dec 2023 |
|
| Loomis, Sayles and | 15k | $1.9M | 100% | Mar 2024 |
|
| Context Capital Management | 5.6k | $6.6M | -100% | Mar 2024 |
|
| Candriam Luxembourg S.C.A. | 600.00 | $702k | 0% | Mar 2024 |
|
Who sold out of Sarepta Therapeutics Inc Note 1.250 9/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Sep 2023 | 154M | $173B |
| Highbridge Capital Management | Dec 2023 | 50M | $51B |
| Opti Capital Management | Sep 2023 | 49M | $55M |
| Flow State Investments | Sep 2023 | 6.7M | $7.5M |
| Weiss Asset Management LP[1 | Dec 2023 | 6.3M | $6.3M |
| CNH Partners | Dec 2023 | 5.6M | $5.7M |
| Balyasny Asset Management | Dec 2023 | 5.0M | $5.1M |
| Leucadia National Corporation | Dec 2023 | 2.6M | $2.7M |
| Alberta Investment Management Corporation | Sep 2023 | 2.5M | $2.8M |
| Nicholas Investments Partners | Sep 2023 | 1.9M | $2.1M |
| Barclays | Dec 2023 | 516k | $524k |
| Brian McDonald | Sep 2023 | 5.0k | $5.6k |